Delivery Order SPE2DB22D1202-SPE2DB23FJBA4
Award Date 9/11/23
Potential Completion Date 9/12/23
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,647 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562125290 MONOVISC 88 MG/4 ML SYRINGE 4ML. The order is for the delivery of MONOVISC, a viscosupplementation product used to treat osteoarthritis of the knee. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will perform as the prime contractor. The place of performance is their facility in Conshohocken, Pennsylvania. The period of performance...
- The Defense Logistics Agency awarded a $10,420.73 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4562521312 MONOVISC 88 MG/4 ML SYRINGE 4ML products. Place of performance will be in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. The contract completion date is October 19, 2023. This delivery order was issued against an existing DLA vehicle to supply joint base medical...
- The Defense Logistics Agency awarded a $5,467 delivery order to Amerisourcebergen Drug Corporation for MONOVISC 88 MG/4 ML SYRINGES. As the prime contractor, Amerisourcebergen will supply 4mL syringes of MONOVISC, a viscosupplementation product used to treat osteoarthritis of the knee, to the DLA under a firm fixed price contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 31 to September 1, 2023. No subcontractors or...
- The Defense Logistics Agency awarded a $4,647 delivery order to Amerisourcebergen Drug Corporation for the supply of 4562025492 MONOVISC 88 MG/4 ML SYRINGE 4ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide pharmaceutical products to DLA locations in Conshohocken, Pennsylvania from September 1-5, 2023. Amerisourcebergen will serve as the prime contractor, with no major subcontractors mentioned. As a key logistics and procurement...
- The Defense Logistics Agency awarded a delivery order valued at $7,821.66 to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. MONOVISC is a hyaluronic acid injection used for the treatment of osteoarthritis knee...
- The Defense Logistics Agency awarded a $4,647 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561677981 MONOVISC 88 MG/4 ML SYRINGE 4ML. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania by August 3, 2023 in support of the Defense Logistics Agency's medical logistics programs. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $27,808 delivery order to Amerisourcebergen Drug Corporation for MONOVISC 88 MG/4 ML SYRINGE 4ML. The firm fixed price order is being carried out under DLA's prime vendor program and calls for the delivery of pharmaceutical products to a facility in Conshohocken, Pennsylvania. Performance will take place from September 7-8, 2023. Amerisourcebergen will serve as the prime contractor, with no major subcontractors mentioned. The order was funded by DLA to...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.73 to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML syringes (4 ML quantity) on August 12, 2025, with a completion date of August 13, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency awarded a $6,419.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 4562114970 MONOVISC 88 MG/4 ML SYRINGE 4ML. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified medical devices to the place of performance in Conshohocken, Pennsylvania within the period of performance from September 11-12, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency,...
- The Defense Logistics Agency awarded a delivery order valued at $1,892.93 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes (4 mL quantity) under a firm fixed price contract. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based viscosupplement used for...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FJBA4Delivery Order
The Defense Logistics Agency awarded a $4,647 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562114960 MONOVISC 88 MG/4 ML SYRINGE 4ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements between September 11-12, 2023. As a leading provider of medical supplies to the Department of Defense, this order for MONOVISC, a hyaluronic acid viscosupplementation injection used to treat knee pain associated with osteoarthritis, aligns with DLA's mission to provide logistics support for all military services.
Generated 12/23/23, 3:53 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/11/23 |